Danaher Korea and Korea Green Foundation Sign Landmark MOU to Drive Urban Forest Development and Climate Solutions

26 August 2024 | Monday | News

Strategic partnership under the "Danaher Korea CSR: 2024 GREEN DAY" initiative aims to combat fine dust pollution, achieve carbon neutrality, and set a new standard for ESG in South Korea with active involvement from Cytiva Korea.

Danaher Korea and the Korea Green Foundation have signed a Memorandum of Understanding (MOU) to jointly develop urban forests and implement a collaborative ESG model focused on climate solutions. This partnership is a key component of the "Danaher Korea CSR: 2024 GREEN DAY" initiative, which aims to reduce fine dust pollution and achieve carbon neutrality in South Korea.

This strategic collaboration marks a significant step forward in Danaher Korea's commitment to sustainable development and environmental stewardship. The partnership will focus on creating green urban spaces that not only enhance the quality of life in urban areas but also contribute to the global fight against climate change.

Cytiva Korea, a key player within Danaher Corporation, is proud to be involved in the planning and execution of this impactful project. "It’s an honor to represent Cytiva Korea in planning and contributing to such a significant project," stated a representative from Cytiva Korea. "We believe that our efforts in developing urban forests will play a crucial role in reducing fine dust and advancing our carbon neutrality goals."

The MOU between Danaher Korea and the Korea Green Foundation reflects a shared commitment to environmental sustainability and social responsibility. Through this collaboration, both organizations aim to set a new standard for ESG (Environmental, Social, and Governance) initiatives in South Korea, demonstrating the power of corporate partnerships in driving meaningful environmental change.

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close